Fenofibrate Tablet
Product Images NDC 82868-018

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 82868-018). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fenofibrate-molecular Structure (4c2fcac5 1c6c 40e2 Bbde 267c4aa2821f 01)

Fenofibrate-molecular Structure (4c2fcac5 1c6c 40e2 Bbde 267c4aa2821f 01)
Chemical structure diagram of the active ingredient fenofibrate showing its molecular arrangement including chlorine, carbon, hydrogen, and oxygen atoms.*
FDA Label Image

82868-018-30 (82868 018 30 Rev A 10 23)

82868-018-30 (82868 018 30   Rev A 10 23)
Label for Fenofibrate Tablets USP 145 mg oral tablets, packaged as 30 tablets. The label indicates prescription use only and provides storage instructions including temperature conditions and moisture protection. Labeler is Northwind Health Company, LLC, with product NDC 82868-018-30.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.